CORPORATION (OTCMKTS:CCYPQ) Files An 8-K Other EventsItem 8.01 Other Events.
On August 17, 2018, RXi Pharmaceuticals Corporation (the “Company”) received written notice (the “Notification Letter”) from the Nasdaq Stock Market notifying the Company that it had regained compliance with the minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Capital Market. The Notification Letter was sent following the filing of the Company’s Form 10-Q dated August 14, 2018, evidencing stockholders’ equity of $3,272,000 for the period ended June 30, 2018.
* * *
